NeuroVive Pharmaceutical AB Soldi per azione
Cos'è Soldi per azione di NeuroVive Pharmaceutical AB?
Soldi per azione di NeuroVive Pharmaceutical AB è 0.02
Qual è la definizione di Soldi per azione?
Il contante per azione è il denaro contante di una società diviso per le azioni della società in circolazione.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Soldi per azione di aziende nel Health Care settore su OTC rispetto a NeuroVive Pharmaceutical AB
Cosa fa NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Aziende con soldi per azione simili a NeuroVive Pharmaceutical AB
- Tuscan II ha Soldi per azione di 0.02
- Ribbit LEAP ha Soldi per azione di 0.02
- Freeman Gold ha Soldi per azione di 0.02
- Sarama Resources Ltd ha Soldi per azione di 0.02
- Wei Yuan Ltd ha Soldi per azione di 0.02
- Neptune Wellness Solutions ha Soldi per azione di 0.02
- NeuroVive Pharmaceutical AB ha Soldi per azione di 0.02
- Streamline Health Solutions, Inc ha Soldi per azione di 0.02
- Universal Security Instruments ha Soldi per azione di 0.02
- VBG International ha Soldi per azione di 0.02
- Infinity Logistics ha Soldi per azione di 0.02
- GreenRoc Mining Plc ha Soldi per azione di 0.02
- Sosandar Plc ha Soldi per azione di 0.02